Dutasteride

Dutasteride blocks both types of an enzyme that turns testosterone into DHT, a hormone linked to pattern hair loss. Oral dutasteride lowers DHT more than oral finasteride, but that does not prove a compounded topical works better. Results vary. A licensed physician decides whether treatment is appropriate.

Oral dutasteride is FDA-approved for an enlarged prostate, not hair loss. Prescribing it for hair loss is an off-label use. Verra offers a compounded topical with minoxidil. Compounded medications are prepared by a licensed pharmacy for one patient and are not FDA-approved. A physician decides whether treatment is appropriate.

Dutasteride and minoxidil target different parts of the hair loss process. Dutasteride reduces DHT production, while minoxidil can support hair growth. Results vary, and the combination is not guaranteed to outperform other options. Verra's compounded topical is prepared by a licensed pharmacy for one patient and is not FDA-approved.

Hair treatments usually need several months before progress can be judged, but there is no established timeline for every compounded dutasteride formula. Results vary. Your physician can set a review schedule based on your treatment. Do not increase the dose or apply it more often to try to speed results.

Apply topical dutasteride with minoxidil only as directed on your prescription label. The amount and schedule depend on your formula. Use it on the prescribed scalp areas, wash your hands afterward, and avoid contact with your eyes or mouth. Ask your pharmacy about drying time and missed doses.

Topical dutasteride with minoxidil may cause scalp itching, redness, dryness, or irritation. Minoxidil may also cause unwanted facial hair or early shedding. Whole-body effects are possible if ingredients enter the bloodstream. Seek urgent care for chest pain, fainting, trouble breathing, or swelling of the face or throat.

Oral dutasteride can cause lower sex drive, erection problems, and changes in ejaculation or semen. Topical dutasteride may also enter the bloodstream, so these risks cannot be ruled out. The risk for a specific compounded formula is uncertain. Tell your physician about fertility plans and any new sexual symptoms.

Dutasteride must not be used during pregnancy because it can harm the development of a male fetus. People who are pregnant or may become pregnant should avoid contact with it. Tell your physician about pregnancy plans, breastfeeding, liver disease, and drug allergies before considering a topical dutasteride prescription.

Dutasteride can interact with some medicines, and oral dutasteride lowers PSA, a blood marker used in prostate care. The effect of a compounded topical on PSA is uncertain. Tell your physician about all medicines, supplements, and scalp products, and tell anyone ordering a PSA test that you use dutasteride.

Stopping topical dutasteride with minoxidil may lead to loss of treatment-related hair gains over time. Results vary. A switch from finasteride needs a physician's plan because the drugs overlap in how they work. Do not combine, replace, or change doses without instructions from your prescribing physician.